DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Levocarnitine (Levocarnitine) - Drug Interactions, Contraindications, Overdosage, etc

 
 



DRUG INTERACTIONS

LEVOCARNITINE drug label information in our database does not contain a dedicated section on drug interactions. Please check subsections of WARNINGS AND PRECAUTIONS as well as other sources.

OVERDOSAGE

There have been no reports of toxicity from levocarnitine overdosage.

Metabolic Disorders

Levocarnitine is easily removed from plasma by dialysis. The intravenous LD50 of levocarnitine in rats is 5.4 g/kg and the oral LD50 of levocarnitine in mice is 19.2 g/kg. Large doses of levocarnitine may cause diarrhea.

CONTRAINDICATIONS

None known.

REFERENCES

  1. Bohmer T, Rynding A, Solberg HE: Carnitine levels in human serum in health and disease. Clin Chim Acta 57:55-61, 1974.
  2. Brooks H, Goldberg L, Holland R et al: Carnitine-induced effects on cardiac and peripheral hemodynamics. J Clin Pharmacol 17:561-578,1977.
  3. Christiansen R, Bremer J: Active transport of butyrobetaine and carnitine into isolated liver cells. Biochem Biophys Acta 448:562-577,1977.
  4. Lindstedt S, Lindstedt G: Distribution and excretion of carnitine14CO2 in the rat. Acta Chim Scand 15:701-702, 1961.
  5. Rebouche CJ, Engel AG: Carnitine metabolism and deficiency syndromes. Mayo Clin Proc 58: 533-540, 1983.
  6. Rebouche CJ, Paulson DJ: Carnitine metabolism and function in humans. Ann Rev Nutr 6:41-68, 1986.
  7. Scriver CR, Beaudet AL, Sly WS, Valle D: The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, 1989.
  8. Schaub J, Van Hoof F, Vis HL: Inborn Errors of Metabolism. Raven Press, New York, 1991.
  9. Marzo A, Arrigoni Martelli E, Mancinelli A, Cardace G, Corbelletta C, Bassani E, Solbiati M: Protein binding of L-carnitine family ccomponents Eur J Drug Met Pharmacokin, Special Issue III: 364-368,1992.
  10. Rebouche C: Quantitative estimation of absorption and degradation of a carnitine supplement by human adults. Metabolism: 1305-1310, 1991

Manufactured by:                                 Manufactured for:

Ben Venue Laboratories, Inc                 Bedford Laboratories™

Bedford, OH 44146                              Bedford, OH 44146

March 2004                                          Div-LVO-P02

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012